Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Clorox Keeps Testing Investors' Patience


Share prices of Clorox (NYSE: CLX) fell over 14% in pre-market trading on Friday after the company reported lower-than-expected second-quarter fiscal year 2022 (FY22) results and slashed its full-year guidance. 

This is yet another quarter when Clorox has disappointed investors, making its banner year in FY20 disappear further in the rearview.

Here's what's driving Clorox stock lower and how to approach investing in the business given what we've just learned.

Continue reading


Source Fool.com

Like: 0
CLX
Share

Comments